Crown (CCK) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
3 Feb, 2026Executive summary
Q2 2024 net sales were $3.04 billion, down from $3.1 billion, as higher beverage can shipments in the Americas and Europe were offset by lower raw material costs and unfavorable FX.
Net income attributable to Crown Holdings rose to $174 million from $157 million, with reported EPS at $1.45 and adjusted EPS at $1.81, both up year-over-year.
Free cash flow for the first half reached a record $178 million, driven by operational performance and reduced capital spending.
Net leverage improved to 3.2x from 4.0x year-over-year.
The company continues to focus on profitable growth, cash flow generation, and shareholder returns through dividends and share repurchases.
Financial highlights
Segment income increased to $437 million from $414 million, led by global beverage operations.
Americas Beverage segment income rose 15% on 10% volume growth; North America up 9%, Brazil up 12%.
European Beverage shipments grew 7%, with segment income up 27%.
Asia Pacific segment margin reached 19% of net sales, with income up nearly 45% despite a 5% volume decline.
Operating cash flow for the first half of 2024 was $343 million, up from $293 million in the prior year period.
Outlook and guidance
Q3 adjusted EPS projected at $1.75–$1.85; full-year 2024 diluted EPS guidance raised to $6.00–$6.25.
2024 adjusted free cash flow expected to be at least $750 million, with capital spending capped at $500 million.
Net leverage expected to fall below 3.0x by year-end, with a long-term target of 2.5x.
Board authorized a new $2 billion share repurchase program through 2027, replacing the previous $3 billion program.
Proceeds of approximately $300 million from the sale of the Eviosys stake are anticipated by year-end 2024.
Latest events from Crown
- Board recommends director elections, auditor ratification, pay approval, and opposes written consent.CCK
Proxy filing23 Mar 2026 - Record EBITDA, strong cash flow, and improved leverage drive positive 2026 outlook.CCK
Q4 20255 Feb 2026 - Strong beverage can growth and higher income offset by pension settlement charges.CCK
Q3 202419 Jan 2026 - Record EBITDA, strong cash flow, and reduced leverage highlight a positive 2025 outlook.CCK
Q4 20248 Jan 2026 - Q1 net income up to $193M, adjusted EPS up 64%, and guidance raised on strong can demand.CCK
Q1 20256 Jan 2026 - Board backs director elections, auditor, and pay, but opposes political spending disclosure proposal.CCK
Proxy Filing1 Dec 2025 - Q2 adjusted EPS up 19%, sales and cash flow strong, and guidance raised for the year.CCK
Q2 20254 Nov 2025 - Q3 2025 delivered higher sales, strong European growth, and raised guidance with robust shareholder returns.CCK
Q3 202530 Oct 2025